As our Operations team tries to be more efficient with pharmacy preparation and decreasing TAT we are moving more and more products away from pharmacy compounding and towards ADC stock via Vial2Bag. Are any institutions providing safeguards/restrictions on high alert high risk medications being supplied in ADC's via vial2bag? For example calcium gluconate vial2bag? or bivalirudin vial2bag? Are you allowing those to be stocked in your ADCs? and if so, have you been successful in adding any safeguards to prevent errors ?

Curious if anyone has come up with a safe way to repackage topical creams/ointments? I am concerned from a human factors perspective about repackaging in slip tip oral syringes. Thanks in advance for any ideas!

If you are unit-dosing opioid tincture, could you please share any guidelines for assigning BUD?

Thank you,
Daniel

Dear All

we are running antibiotic stewardship programme. Antibiotic consumption and their data calculation is most important part in stewardship programme. kindly any one give the suggestion on above topic.

we have Total patient who are on antibiotic and Antibiotic wise quantity details.

Kindly focus on brief reply.

Hello,
Does anyone use reports from Epic or their EMR to obtain data regarding medication errors/events? If so what type of data are you able to obtain?

As with all Safety Reporting Systems our current system relies on staff to voluntarily report and so we are looking at ways to capture more data reliably through Epic/EMR. We wanted to see if anyone else has had success doing so.

Thank you,
Madiha

Hi Everyone,

Does anyone have a definition of what a "not an opioid naive pediatric patient" is? We have a definition for an adult pt such as having been on morphine sulfate, hydromorphone but I was wondering if anyone has one for a pediatric patient and what doses of opioids will qualify the patient to be not an opioid naive pt.

Hello all,

Trying to get a feel for current practice.

1) Do you allow use of lidocaine as a diluent for intramuscular injections (ceftriaxone most commonly)
2) Do you have any weight or age restrictions for this use?

Thanks,

Zach Hodges, PharmD, BCCCP
Medication Safety Officer
Tucson Medical Center

HI All-Just sending a f/u email on this topic..

How do you draw up a patient-specific dose of an inhaled med? It is my understanding that the product needs to remain sterile, therefore doses should be drawn up in an ISO Class 5 environment into a sterile syringe. I cannot find any "sterile" oral syringes, however...

1. Are you drawing up inhaled meds in your IV room hood?

2. Do you dispense them in an IV syringe or an oral syringe?

3. If you do use oral syringes, are you using a STERILE oral syringe? If so, what manufacturer are you using?

As a health system we are working on the USP 800 guidelines/Hazardous drug list.

I was curious what other institutions are requiring on the nursing end for the IV drugs in table 2 and 3 of the hazardous drug list. Some of the ones that are concerning to me are Dilantin, Valproic Acid, Zometa, Pamidronate.
1. Are you requiring nurses to handle these as chemo agents as the NIOSH would suggest? chemo gloves, gown, and CTSD for administration ?
2. If not what requirements do you have in place ?

Any help is greatly appreciated.
Nancy

As a health system we are working on the USP 800 guidelines/Hazardous drug list.

I was curious what other institutions are requiring on the nursing end for the IV drugs in table 2 and 3 of the hazardous drug list. Some of the ones that are concerning to me are Dilantin, Valproic Acid, Zometa, Pamidronate.
1. Are you requiring nurses to handle these as chemo agents as the NIOSH would suggest? chemo gloves, gown, and CTSD for administration ?
2. If not what requirements do you have in place ?

Any help is greatly appreciated.
Nancy